Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00073749 · COMPLETED

Trial details

NCT number: NCT00073749
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2003-08-01
Primary completion: 2010-12-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.